Board Meeting6 May 2026, 03:05 pm
Cohance Lifesciences Board Meeting on 12/05/2026
AI Summary
Cohance Lifesciences Ltd has scheduled a Board of Directors meeting on May 12, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. The trading window, which was previously closed on March 27, 2026, will remain closed until May 14, 2026.
Key Highlights
- Board meeting scheduled for May 12, 2026, to approve audited financial results.
- Financial results are for the quarter and year ended March 31, 2026.
- Trading window remains closed until May 14, 2026.
Price Impact
More from SUVENPHAR